Tisotumab vedotin is an antibody-drug conjugate (ADC) targeting tissue factor (TF), consisting of the fully human monoclonal antibody (TF-011) conjugated with monomethyl auristatin E (MMAE). It exhibits significant antitumor activity and is suitable for research on the treatment of advanced or metastatic solid tumors.
Reinheit:
95.00%
CAS Nummer:
[1418731-10-8]
Target-Kategorie:
Antibody-Drug Conjugates (ADCs)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten